Works matching IS 15228517 AND DT 2014 AND VI 16 AND IP suppl_2

Results: 436

P17.46 LATE PSEUDOPROGRESSION IN GLIOBLASTOMA PATIENTS: COMPARABLE ANALYSIS WITH REAL TUMOR PROGRESSION.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii98, doi. 10.1093/neuonc/nou174.375
By:
- Kamer, S.;
- Akagunduz, O.;
- Ertan, Y.;
- Akalın, T.;
- Özgiray, E.;
- Oner, K.;
- Eraslan, C.;
- Çallı, C.;
- Oktar, N.;
- Anacak, Y.
Publication type:
Article
P04.09 THE PROGNOSTIC POTENTIAL OF CD133 AND NESTIN IN A POPULATION-BASED COHORT OF GLIOMA PATIENTS.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii38, doi. 10.1093/neuonc/nou174.141
By:
- Dahlrot, R.H.;
- Hansen, S.;
- Schroeder, H.D.;
- Jensen, S.S.;
- Hjelmborg, J.;
- Kristensen, B.W.
Publication type:
Article
O5.04 PRELIMINARY RESULTS OF THE GALA-5 STUDY: AN EVALUATION OF THE TOLERABILITY AND FEASIBILITY OF COMBINING 5-AMINO-LEVULINIC ACID (5-ALA) WITH CARMUSTINE WAFERS (GLIADEL) IN THE SURGICAL MANAGEMENT OF PRIMARY GLIOBLASTOMA.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii10
By:
- Watts, C.;
- Wanek, K.;
- Smith, P.;
- Counsell, N.
Publication type:
Article
P15.17 PSYCHOSOCIAL SUPPORT BY MEDICAL SOCIAL WORKER IS BENEFICIAL FOR PATIENTS WITH MALIGN BRAIN TUMORS.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii77, doi. 10.1093/neuonc/nou174.296
By:
- Gröntoft, M.;
- Westermark, M.;
- Hylin, S.;
- Stragliotto, G.
Publication type:
Article
O6.03 A PHASE II TRIAL OF AUTOLOGOUS DENDRITIC CELLS VACCINATION AND RADIO-CHEMOTHERAPY FOLLOWING FLUORESCENCE-GUIDED SURGERY IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS: PRELIMINARY CLINICAL RESULTS OF THE «DEND/GBM» TRIAL.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii12, doi. 10.1093/neuonc/nou174.44
By:
- Gállego Pérez-Larraya, J.;
- Tejada-Solís, S.;
- de Cerio, A.L.;
- Inogés, S.;
- Espinós, J.;
- Díez-Valle, R.
Publication type:
Article
P18.02 A COMPARISON OF THE EFFECTS OF ATTENTION DEFICIT ON REHABILITATION FUNCTIONAL OUTCOMES IN BRAIN TUMOR PATIENTS AND SUBACUTE STROKE PATIENTS.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii110, doi. 10.1093/neuonc/nou174.426
By:
- Young, H. Eun;
- Im, S.
Publication type:
Article
P04.06 TERT PROMOTER MUTATIONS CONTRIBUTE TO SUBSET PROGNOSTICATION OF LOWER GRADE GLIOMAS.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii37, doi. 10.1093/neuonc/nou174.138
By:
- Chan, A.K.;
- Yao, Y.;
- Zhang, Z.;
- Chung, N.Y.;
- Li, K.K.;
- Chan, D.T.;
- Poon, W.S.;
- Zhou, L.;
- Ng, H.K.
Publication type:
Article
P18.09 STRESS INDUCED IMMUNE DYSFUNCTION IN NEURO-ONCOLOGY CAREGIVERS.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii112, doi. 10.1093/neuonc/nou174.433
By:
- Sherwood, P.R.;
- Weimer, J.;
- Price, T.;
- Ren, D.;
- Lieberman, F.;
- Donovan, H.
Publication type:
Article
O9.03 BRAIN TUMORS IN SWEDEN: DATA FROM A POPULATION BASED REGISTRY 1999-2012.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii20, doi. 10.1093/neuonc/nou174.74
By:
- Asklund, T.;
- Malmström, A.;
- Bergqvist, M.;
- Björ, O.;
- Henriksson, R.
Publication type:
Article
P18.04 CLINICAL PROGRESS AND SURVIVAL OF PATIENTS WITH GLIOBLASTOMA AFTER HYPO-FRACTIONATED RADIOTHERAPY.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii111, doi. 10.1093/neuonc/nou174.428
By:
- Jakes, A.D.;
- Boyer, M.;
- Hatfield, P.
Publication type:
Article
P17.47 COMPREHENSIVE PROTEOMIC PROFILING OF BEVACIZUMAB-RESISTANT GLIOBLASTOMA MULTIFORME.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii98, doi. 10.1093/neuonc/nou174.376
By:
- Kaufman, K.L.;
- Ly, L.;
- McKay, M.;
- Mallawaaratchy, D.M.;
- Mactier, S.;
- Crossett, B.;
- Molloy, M.;
- Buckland, M.E.;
- McDonald, K.L.;
- Christopherson, R.I.
Publication type:
Article
O8.03 LOW GRADE DIFFUSE ASTROCYTOMA - PROGNOSTIC FACTORS TO ANAPLASTIC TRANSFORMATION.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii18, doi. 10.1093/neuonc/nou174.64
By:
- Izquierdo, C.;
- Majos, C.;
- Simó, M.;
- Lucas, A.;
- Macià, M.;
- Plans, G.;
- Gil, M.;
- Velasco, R.;
- Bruna, J.
Publication type:
Article
P17.71 ROLE OF ATRX AND TERT EXPRESSION AS DIAGNOSTIC AND PROGNOSTIC FACTORS ON ANAPLASTIC GLIOMAS.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii104, doi. 10.1093/neuonc/nou174.400
By:
- Patanè, M.;
- Calatozzolo, C.;
- Mazzetti, S.;
- Nunziata, R.;
- Spinello, S.;
- Farinotti, M.;
- Finocchiaro, G.;
- Pollo, B.
Publication type:
Article
O10.02 MITOTIC INDEX, MICROVASCULAR PROLIFERATION AND NECROSIS DEFINE THREE GROUPS OF 1P/19Q CO-DELETED ANAPLASTIC OLIGODENDROGLIOMAS ASSOCIATED WITH DIFFERENT GENOMIC ALTERATIONS.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii23, doi. 10.1093/neuonc/nou174.83
By:
- Figarella-Branger, D.;
- Mokhtari, K.;
- Dehais, C.;
- Jouvet, A.;
- Uro-Coste, E.;
- Colin, C.;
- Carpentier, C.;
- Ducray, F.;
- Idbaih, A.;
- Network, French POLA
Publication type:
Article
P15.06 QUALITY OF PATIENTS LIFE WITH METASTATIC TUMORS OF THE SPINE AND SPINAL CORD.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii75, doi. 10.1093/neuonc/nou174.285
By:
- Gazieva, S.G.;
- Tolibova, N.;
- Niyozova, S.;
- Prokhorova, A.
Publication type:
Article
P17.50 PHASE II STUDY OF ARSENIC TRIOXIDE AND TEMOZOLOMIDE IN COMBINATION WITH RADIATION THERAPY IN PATIENTS WITH MALIGNANT GLIOMAS.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii99, doi. 10.1093/neuonc/nou174.379
By:
- Kumthekar, P.;
- Grimm, S.A.;
- Marymont, M.;
- Mehta, M.;
- Chandler, J.;
- Muro, K.;
- Jovanovic, B.;
- Helenowski, I.;
- McCarthy, K.;
- Raizer, J.
Publication type:
Article
P10.01 PARANEOPLASTIC BRAINSTEM ENCEPHALITIS AS PRESENTING SYMPTOM OF MERKEL CELL CARCINOMA (MCC) FOLLOWED BY INTRACRANIAL AND LEPTOMENINGEAL DIFFUSION.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii58, doi. 10.1093/neuonc/nou174.221
By:
- Ferrandi, D.;
- Prevost, C.;
- Mascolo, M.;
- Bottaro, R.;
- Melato, M.;
- Palermo, M.;
- Varese, P.;
- Traverso, E.;
- Ruiz, L.
Publication type:
Article
O6.08 COMBINED ANALYSIS OF TERT, EGFR AND IDH STATUS DEFINE DISTINCT PROGNOSTIC CLASSES OF GLIOBLASTOMA.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii14, doi. 10.1093/neuonc/nou174.49
By:
- Labussiere, M.;
- Boisselier, B.;
- Mokhtari, K.;
- Di Stefano, A.;
- Rahimian, A.;
- Saulnier, O.;
- Paterra, R.;
- Finocchiaro, G.;
- Marie, Y.;
- Sanson, M.
Publication type:
Article
P10.03 OPSOCLONUS MYOCLONUS SYNDROME ASSOCIATED WITH LUNG ADENOCARCINOMA.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii58, doi. 10.1093/neuonc/nou174.223
By:
- Matas, A.F.M.R.;
- Veiga, A.S.B.T.;
- Gabriel, J.P.M.S.;
- Silva, M.R.
Publication type:
Article
P17.55 UNRAVELLING GRADE 3 GLIOMAS.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii100, doi. 10.1093/neuonc/nou174.384
By:
- Mathew, R.;
- Goacher, E.;
- Bhargava, D.;
- Chakrabarty, A.;
- Roberts, P.;
- Goodden, J.;
- Loughrey, C.;
- Chumas, P.
Publication type:
Article
P01.06 HIF-1 AND HIF-2 AS POSIBLE NEW TARGETS IN THE TREATMENT OF VON HIPPEL-LINDAU DISEASE HEMANGIOBLASTOMAS.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii27, doi. 10.1093/neuonc/nou174.99
By:
- Viñas, D.;
- Serrano-Heras, G.;
- Perona-Morata, A.B.;
- De Andres, P.;
- Fortes, J.;
- Segura, T.;
- De Campos, J.M.
Publication type:
Article
O9.10 ANTI-EPILEPTIC TREATMENT IN GLIOMA, A NORWEGIAN POPULATION-BASED STUDY.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii22, doi. 10.1093/neuonc/nou174.81
By:
- Knudsen-Baas, K.M.;
- Johannesen, T.B.;
- Engeland, A.;
- Engelsen, B.A.;
- Storstein, A.M.;
- Owe, J.F.
Publication type:
Article
P17.91 CLINICAL VARIABLES SERVE AS PREDICTIVE FACTORS IN A MODEL FOR CLINICAL RESPONSE TO BEVACIZUMAB IN RECURRENT GLIOBLASTOMA MULTIFORME: AN OBSERVATIONAL STUDY OF A COHORT OF CONSECUTIVE NON-SELECTED PATIENTS FROM A SINGLE INSTITUTION.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii109, doi. 10.1093/neuonc/nou174.420
By:
- Urup, T.;
- Grunnet, K.;
- Christensen, I.J.;
- Michaelsen, S.R.;
- Broholm, H.;
- Stockhausen, M.T.;
- Lassen, U.;
- Poulsen, H.S.
Publication type:
Article
P16.07 BEVACIZUMAB AS PALLIATIVE TREATMENT OF FAMILIAL SCHWANNOMATOSIS.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii79, doi. 10.1093/neuonc/nou174.304
By:
- Clement, P.M.;
- Blockmans, D.;
- Bechter, O.E.;
- Van Calenbergh, F.;
- Legius, E.
Publication type:
Article
P13.04 A STUDY ON DOSIMETRIC PERFORMANCE OF 5 MM MLCS FOR VMAT BASED STEREOTACTIC RADIOSURGERY.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii66, doi. 10.1093/neuonc/nou174.250
By:
- Robinson, M.;
- Padmanaban, S.;
- Van den Heuvel, F.;
- Blesing, C.
Publication type:
Article
P17.62 THE IMPORTANCE OF DELAYED PSEUDOPROGRESSION AND THE PROBLEM WITH RANO IN GBM.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii101, doi. 10.1093/neuonc/nou174.391
By:
- Neuwelt, E.A.;
- Muldoon, L.L.;
- Gahramanov, S.
Publication type:
Article
O4.02 EXOSOMAL MIRNA FROM GLIOMA-ASSOCIATED MESENCHYMAL STEM CELLS PROMOTE GLIOMA GROWTH AND PROGRESSION.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii7, doi. 10.1093/neuonc/nou174.23
By:
- Figueroa, J.M.;
- Shahar, T.;
- Hossain, A.;
- Gumin, J.;
- Lang, F.
Publication type:
Article
P11.07 BLOOD-BRAIN BARRIER DISRUPTION AND INTRA-ARTERIAL METHOTREXATE-BASED THERAPY FOR NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA: A SINGLE-INSTITUTION EXPERIENCE.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii60, doi. 10.1093/neuonc/nou174.230
By:
- Kobyakov, G.L.;
- Aronov, M.S.;
- Lubnin, A.Y.;
- Yakovlev, S.B.;
- Serova, N.K.;
- Tropinskaya, O.F.;
- Shishkina, L.V.;
- Ryzhova, M.V.;
- Poddubsky, A.A.;
- Inozemtceva, M.V.
Publication type:
Article
P17.29 IDENTIFICATION OF NOVEL MOLECULAR TARGETS FOR TEMOZOLOMIDE-BASED THERAPIES AGAINST GLIOBLASTOMA: A COMPREHENSIVE SHRNA-BASED SCREEN OF DNA REPAIR FACTORS.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii93, doi. 10.1093/neuonc/nou174.358
By:
- Erasimus, H.;
- Fritah, S.;
- Haan, S.;
- Niclou, S.P.;
- Van Dyck, E.
Publication type:
Article
P01.18 AUTOCRINE VEGFC-VEGFR2 SIGNALING IS OF IMPORTANCE FOR THE GROWTH OF GLIOBLASTOMA MULTIFORME.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii31, doi. 10.1093/neuonc/nou174.111
By:
- Michaelsen, S.R.;
- Nedergaard, M.K.;
- Villingshøj, M.;
- Pedersen, P.;
- Stockhausen, M.;
- Poulsen, H.S.
Publication type:
Article
O5.09 VENTRICULAR HIGH GRADE GLIOMA: NEUROENDOSCOPY AND ADJUVANT THERAPY.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii11, doi. 10.1093/neuonc/nou174.40
By:
- Oppido, P.A.;
- Cattani, F.;
- Carapella, C.M.;
- Villani, V.
Publication type:
Article
O1.07 INTRACRANIAL HEMANGIOPERICYTOMAS LACK TYPICAL CYTOGENETIC AND EPIGENETIC FEATURES OF MENINGIOMAS: A COMPREHENSIVE MOLECULAR GENETIC STUDY.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii2, doi. 10.1093/neuonc/nou174.7
By:
- Kraemer, D.;
- Orie, S.I.;
- Ketter, R.;
- Oertel, J.;
- Urbschat, S.
Publication type:
Article
P17.75 UTILITY OF 3D SURGICAL PLANNING FOR RESECTION OF HIGH-GRADE GLIOMAS.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii105, doi. 10.1093/neuonc/nou174.404
By:
- Rozumenko, A.V.;
- Rozumenko, V.D.
Publication type:
Article
P16.26 MINIMUM APPARENT DIFFUSION COEFFICIENT MEASUREDBY 3T MR IMAGES IN GLIOBLASTOMA AND O6-METHYLGUANINE-DNA-METHYTRANSFERASE GENE PROMOTER METHYLATED STATUS.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii84, doi. 10.1093/neuonc/nou174.321
By:
- Asteggiano, F.;
- Vella, A.;
- Scola, E.;
- Pirola, E.;
- Minichiello, M.;
- Miozzo, M.;
- Caroli, M.;
- Bergamasco, L.;
- Rampini, P.;
- Triulzi, F.
Publication type:
Article
P16.10 DIAGNOSIS OF PSEUDOPROGRESSION IN PATIENTS WITH GLIOBLASTOMA USING AMINO ACID PET.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii80, doi. 10.1093/neuonc/nou174.306
By:
- Galldiks, N.;
- Dunkl, V.;
- Stoffels, G.;
- Hutterer, M.;
- Rapp, M.;
- Kebir, S.;
- Goldbrunner, R.;
- Ruge, M.I.;
- Schmidt, M.;
- Langen, K.
Publication type:
Article
P18.08 A MULTICENTRIC, OBSERVATIONAL, NON INTERVENTIONAL STUDY OF EFFICACY AND SAFETY OF LACOSAMIDE FOR THE TREATMENT OF EPILEPTIC SEIZURES IN PATIENTS WITH BRAIN TUMORS.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii112, doi. 10.1093/neuonc/nou174.432
By:
- Pardo-Moreno, J.;
- Sepúlveda, J.;
- Conde-Moreno, A.;
- Barón, M.;
- Reynes, G.;
- Belenguer, A.
Publication type:
Article
P04.13 EXPRESSION OF PLURIPOTENCY STEMNESS GENES IN HUMAN GLIOMAS OF DIFFERENT TUMOR GRADES BEFORE AND AFTER CHEMOTHERAPY.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii39, doi. 10.1093/neuonc/nou174.145
By:
- Dreher, L.;
- Röhn, G.;
- Perrech, M.;
- Goldbrunner, R.;
- Timmer, M.
Publication type:
Article
P05.03 EFFECT OF COMBINED THERAPY WITH BEVACIZUMAB AND TEMOZOLOMIDE (TMZ) IN PEDIATRIC MALIGNANT GLIOMAS (MG).
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii43, doi. 10.1093/neuonc/nou174.161
By:
- Geludkova, O.G.;
- Borodina, I.D.;
- Melikian, A.G.;
- Kushel, Y.V.;
- Shishkina, L.V.;
- Rizhova, M.V.;
- Gorbatih, S.V.;
- Popov, V.E.;
- Pavlova, E.V.;
- Scherbenko, O.I.
Publication type:
Article
O4.03 GLIOBLASTOMA STIMULATED ANGIOGENESIS IS MEDIATED BY MMP-3 ACTIVATED MMP-1 VIA BRAIN ENDOTHELIAL CELL ASSOCIATED PROTEASE ACTIVATED RECEPTOR 1 (PAR1) AND IS ENHANCED UNDER HYPOXIC CONDITIONS.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii7, doi. 10.1093/neuonc/nou174.24
By:
- Briggs, S.;
- Stephenson, K.;
- Holliday, J.;
- Peckham, R.;
- Arthur, D.;
- Papanikolaou, M.;
- Butt, A.;
- Pickford, A.;
- Pilkington, G.;
- Fillmore, H.L.
Publication type:
Article
O5.01 STANDARDS AND ADVANCED TESTING FOR INTRAOPERATIVE LANGUAGE AND COGNITIVE MAPPING.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii9, doi. 10.1093/neuonc/nou174.32
By:
- Comi, A.;
- Riva, M.;
- Casarotti, A.;
- Fava, E.;
- Pessina, F.;
- Papagno, C.;
- Bello, L.
Publication type:
Article
P16.19 THE EFFECTS OF BEVACIZUMAB ON MR-IMAGING AND 1H-MR-SPECTROSCOPY (MRS) IN PATIENTS WITH HIGH GRADE GLIOMAS.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii82, doi. 10.1093/neuonc/nou174.315
By:
- Knecht, U.;
- Slotboom, J.;
- Ochsenbein, A.;
- Beck, J.;
- Pica, A.;
- Wiest, R.
Publication type:
Article
P16.06 EARLY PERFUSION CHANGES IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMAS TREATED WITH BEVACIZUMAB: PRELIMINARY EVALUATION BY THE PARAMETRIC RESPONSE MAP DERIVED FROM DYNAMIC CONTRAST-ENHANCED MRI.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii79, doi. 10.1093/neuonc/nou174.303
By:
- Vidiri, A.;
- Marzi, S.;
- Piludu, F.;
- Villani, V.;
- Antenucci, A.;
- Terrenato, I.;
- Fabi, A.;
- Pace, A.;
- Carapella, C.M.
Publication type:
Article
O7.03 IDH-1 MUTATED GLIOBLASTOMAS HAVE A LESS INVASIVE PHENOTYPE THAN IDH-1 WILD TYPE GLIOBLASTOMAS: A DIFFUSION TENSOR IMAGING STUDY.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii15, doi. 10.1093/neuonc/nou174.54
By:
- Price, S.J.;
- Boonzaier, N.R.;
- Lupson, V.;
- Larkin, T.
Publication type:
Article
O3.03 THE SPECTRUM OF LATE PAROXYSMAL NEUROLOGICAL SYNDROMES AFTER BRAIN IRRADIATION.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii5, doi. 10.1093/neuonc/nou174.17
By:
- Berzero, G.;
- Group, Pavia Neuro-oncology;
- Ducray, F.;
- Giometto, B.;
- Silvani, A.;
- Salmaggi, A.;
- Eoli, M.;
- Finocchiaro, G.;
- Vidiri, A.;
- Pace, A.
Publication type:
Article
P08.27 LEPTOMENINGEAL METASTASES: A RANO PROPOSAL FOR RESPONSE CRITERIA.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii56, doi. 10.1093/neuonc/nou174.215
By:
- Chamberlain, M.;
- Junck, L.;
- Brandsma, D.;
- Soffietti, R.;
- Rudà, R.;
- Raizer, J.;
- Boogerd, W.;
- Taillibert, S.;
- Groves, M.D.;
- Le Rhun, E.
Publication type:
Article
P13.02 PROTON THERAPY FOR BRAIN AND SKULL BASE TUMORS AT THE NEW OPENING TRENTO FACILITY.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii65, doi. 10.1093/neuonc/nou174.248
By:
- Amelio, D.;
- Cianchetti, M.;
- Rombi, B.;
- Vennarini, S.;
- Dionisi, F.;
- Vinante, L.;
- Amichetti, M.
Publication type:
Article
P18.01 COMPLEMENTARY THERAPY USE IN A COHORT OF SWISS GLIOMA PATIENTS.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii110, doi. 10.1093/neuonc/nou174.425
By:
- Eisele, G.;
- Roelcke, U.;
- Conen, K.;
- Huber, F.;
- Weiss, T.;
- Hofer, S.;
- Heese, O.;
- Westphal, M.;
- Weller, M.
Publication type:
Article
P11.08 CENTRAL NERVOUS SYSTEM LYMPHOMA IN A PATIENT WITH MYCOSIS FUNGOIDES.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii61, doi. 10.1093/neuonc/nou174.231
By:
- Koeppen, S.;
- Göricke, S.;
- Rompoti, N.;
- Sakarou, M.;
- Keyvani, K.
Publication type:
Article
P17.20 PATTERNS OF CARE AND OUTCOME FOR PATIENTS WITH RECURRENT GLIOBLASTOMA.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii91, doi. 10.1093/neuonc/nou174.350
By:
- De Cock, L.;
- Sala, Q.;
- Barrie, M.;
- Boucard, C.;
- Metellus, P.;
- Tabouret, E.;
- Padovani, L.;
- Figarella-Branger, D.;
- Dufour, H.;
- Chinot, O.
Publication type:
Article
P17.41 CLINICAL MANAGEMENT AND OUTCOME OF HISTOLOGICALLY VERIFIED ADULT BRAINSTEM GLIOMAS IN SWITZERLAND: A RETROSPECTIVE ANALYSIS OF 21 PATIENTS.
Published in:
Neuro-Oncology, 2014, v. 16, n. suppl_2, p. ii96, doi. 10.1093/neuonc/nou174.370
By:
- Hundsberger, T.;
- Tonder, M.;
- Andreas, H.;
- Brügge, D.;
- Roelcke, U.;
- Putora, P.M.;
- Stupp, R.;
- Weller, M.
Publication type:
Article